Abstract

The rapid emergence of a highly pathogenic, readily transmissible coronavirus has resulted in a global pandemic, affecting millions and destabilizing economies. This catastrophe triggered a clarion call for the immediate deployment of a protective vaccine. We describe the unique challenges of developing a vaccine against SARS-CoV-2 in a pandemic setting.

Original languageEnglish
Pages (from-to)699-703
Number of pages5
JournalCell Host and Microbe
Volume27
Issue number5
DOIs
StatePublished - May 13 2020

Fingerprint

Dive into the research topics of 'The Challenges of Vaccine Development against a New Virus during a Pandemic'. Together they form a unique fingerprint.

Cite this